financetom
Business
financetom
/
Business
/
Quantum Swings to Fiscal 2024 Loss, Revenue Drops; Q1 Guidance Set -- Shares Fall After Hours
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Quantum Swings to Fiscal 2024 Loss, Revenue Drops; Q1 Guidance Set -- Shares Fall After Hours
Jun 17, 2024 2:41 PM

05:16 PM EDT, 06/17/2024 (MT Newswires) -- Quantum (QMCO) reported a fiscal 2024 non-GAAP net loss late Monday of $0.29 per diluted share, compared with a gain of $0.03 per diluted share a year earlier.

Revenue for the year ended March 31 was $311.6 million, down from $422.1 million a year earlier.

For Q1, the company said it expects a non-GAAP basic net loss per share of $0.09, plus or minus $0.02, on revenue of between $70 million and $74 million.

No comparable estimates were available on Capital IQ.

The company's shares were falling past 33% in after-hours activity.

Price: 0.5195, Change: -0.26, Percent Change: -33.40

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Velo3D Stock Friday?
What's Going On With Velo3D Stock Friday?
Mar 27, 2026
Velo3D Inc ( VELO ) shares are trading lower Friday morning as investors continued to react to the company's fourth-quarter results, which were released after the close on Tuesday and came in ahead of Wall Street expectations. This week’s move lower came despite a mix of earnings beats, improving liquidity, a growing backlog and commentary about demand heading into 2026....
AnaptysBio Board Approves Spin-Off of First Tracks Bio, Repurchase of $100 Million Shares
AnaptysBio Board Approves Spin-Off of First Tracks Bio, Repurchase of $100 Million Shares
Mar 27, 2026
09:58 AM EDT, 03/27/2026 (MT Newswires) -- AnaptysBio's ( ANAB ) board has approved the planned spin-off of First Tracks Biotherapeutics and a repurchase program for up to $100 million shares, the company said in separate Friday statements. AnaptysBio ( ANAB ) said its shareholders will get one First Tracks Bio share for every AnaptysBio ( ANAB ) share they...
Brown-Forman's Potential Merger With Pernod Ricard Faces Execution Risks, RBC Says
Brown-Forman's Potential Merger With Pernod Ricard Faces Execution Risks, RBC Says
Mar 27, 2026
09:59 AM EDT, 03/27/2026 (MT Newswires) -- Brown-Forman's (BF.A, BF.B) potential merger with Pernod Ricard is likely to face high execution risk due to cultural differences between the companies, RBC Capital Markets said in a Friday note. Jack Daniel's maker Brown-Forman and French beverages firm Pernod Ricard separately announced Thursday they were in talks about a possible merger of equals,...
Planet Labs to Redeem Outstanding Public Warrants
Planet Labs to Redeem Outstanding Public Warrants
Mar 27, 2026
10:05 AM EDT, 03/27/2026 (MT Newswires) -- Planet Labs (PL) said Friday it will redeem all outstanding public warrants issued during its initial public offering for $0.01 per warrant on April 27. This comes after the company's stock closed at or above $18 per share for 20 trading days within a 30-day window, the company said. Investors can exercise their...
Copyright 2023-2026 - www.financetom.com All Rights Reserved